- Home
- DIAX vs BVS Comparison
DIAX vs BVS Comparison
Compare DIAX & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DIAX | BVS |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | United States |
| Employees | N/A | 930 |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 561.9M | 597.6M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | DIAX | BVS |
|---|---|---|
| Price | $14.47 | $8.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.25 |
| AVG Volume (30 Days) | 117.2K | ★ 312.3K |
| Earning Date | 01-01-0001 | 03-05-2026 |
| Dividend Yield | ★ 7.93% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.42 |
| Revenue Next Year | N/A | $6.46 |
| P/E Ratio | ★ N/A | $27.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.42 | $5.81 |
| 52 Week High | $15.85 | $10.13 |
Technical Indicators
Market Signals| Indicator | DIAX | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 26.76 | 57.21 |
| Support Level | $14.13 | $6.42 |
| Resistance Level | $14.97 | $9.01 |
| Average True Range (ATR) | 0.22 | 0.38 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 0.00 | 54.81 |
Price Performance
Historical ComparisonAbout DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.